Children with Chronic Immune Thrombocytopenia Exhibit High Expression of Human Endogenous Retroviruses TRIM28 and SETDB1
- PMID: 37628621
- PMCID: PMC10454145
- DOI: 10.3390/genes14081569
Children with Chronic Immune Thrombocytopenia Exhibit High Expression of Human Endogenous Retroviruses TRIM28 and SETDB1
Abstract
Chronic immune thrombocytopenia (CITP) is an autoimmune disease whose underlying biologic mechanisms remain elusive. Human endogenous retroviruses (HERVs) derive from ancestral infections and constitute about 8% of our genome. A wealth of clinical and experimental studies highlights their pivotal pathogenetic role in autoimmune diseases. Epigenetic mechanisms, such as those modulated by TRIM28 and SETDB1, are involved in HERV activation and regulation of immune response. We assessed, through a polymerase chain reaction real-time Taqman amplification assay, the transcription levels of pol genes of HERV-H, HERV-K, and HERV-W; env genes of Syncytin (SYN)1, SYN2, and HERV-W; as well as TRIM28 and SETDB1 in whole blood from 34 children with CITP and age-matched healthy controls (HC). The transcriptional levels of all HERV sequences, with the exception of HERV-W-env, were significantly enhanced in children with CITP as compared to HC. Patients on eltrombopag treatment exhibited lower expression of SYN1, SYN2, and HERV-W-env as compared to untreated patients. The mRNA concentrations of TRIM28 and SETDB1 were significantly higher and were positively correlated with those of HERVs in CITP patients. The over-expressions of HERVs and TRIM28/SETDB1 and their positive correlations in patients with CITP are suggestive clues of their contribution to the pathogenesis of the disease and support innovative interventions to inhibit HERV and TRIM28/SETDB1 expressions in patients unresponsive to standard therapies.
Keywords: SETDB1; TRIM28; autoimmune disease; children; endogenous retroviruses; genetic pathomechanism; primary immune thrombocytopenia.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Pregnancy Is Associated with Impaired Transcription of Human Endogenous Retroviruses and of TRIM28 and SETDB1, Particularly in Mothers Affected by Multiple Sclerosis.Viruses. 2023 Mar 9;15(3):710. doi: 10.3390/v15030710. Viruses. 2023. PMID: 36992419 Free PMC article.
-
Adults with celiac disease exhibit overexpression of endogenous retroviruses, TRIM28, and SETDB1 despite gluten-free diet.Virus Res. 2025 Sep;359:199613. doi: 10.1016/j.virusres.2025.199613. Epub 2025 Aug 5. Virus Res. 2025. PMID: 40769425 Free PMC article.
-
Enhanced Expression of Human Endogenous Retroviruses, TRIM28 and SETDB1 in Autism Spectrum Disorder.Int J Mol Sci. 2022 May 25;23(11):5964. doi: 10.3390/ijms23115964. Int J Mol Sci. 2022. PMID: 35682642 Free PMC article.
-
Do Human Endogenous Retroviruses Contribute to Multiple Sclerosis, and if So, How?Mol Neurobiol. 2019 Apr;56(4):2590-2605. doi: 10.1007/s12035-018-1255-x. Epub 2018 Jul 25. Mol Neurobiol. 2019. PMID: 30047100 Free PMC article. Review.
-
Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?Biochim Biophys Acta. 2011 Feb;1812(2):162-76. doi: 10.1016/j.bbadis.2010.07.016. Epub 2010 Aug 6. Biochim Biophys Acta. 2011. PMID: 20696240 Free PMC article. Review.
Cited by
-
Patients with Irritable Bowel Syndrome Exhibit Aberrant Expression of Endogenous Retroviruses and SETDB1.Cells. 2025 Jan 29;14(3):196. doi: 10.3390/cells14030196. Cells. 2025. PMID: 39936987 Free PMC article.
-
SETDB1 amplification in osteosarcomas: Insights from its role in healthy tissues and other cancer types.Oncotarget. 2025 Feb 12;16:51-62. doi: 10.18632/oncotarget.28688. Oncotarget. 2025. PMID: 39945463 Free PMC article. Review.
-
Enhanced Transcription of Human Endogenous Retroviruses and TRIM28 Downregulation in Patients with Inflammatory Bowel Disease.Viruses. 2024 Oct 5;16(10):1570. doi: 10.3390/v16101570. Viruses. 2024. PMID: 39459904 Free PMC article.
-
The intersection of epigenetics and immune thrombocytopenia: new insights into disease mechanisms and treatments.Mol Biol Rep. 2025 Feb 21;52(1):257. doi: 10.1007/s11033-025-10363-z. Mol Biol Rep. 2025. PMID: 39982580 Review.
References
-
- Rodeghiero F., Stasi R., Gernsheimer T., Michel M., Provan D., Arnold D.M., Bussel J.B., Cines D.B., Chong B.H., Cooper N., et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood. 2009;113:2386–2393. - PubMed
-
- Terrell D.R., Beebe L.A., Vesely S.K., Neas B.R., Segal J.B., George J.N. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am. J. Hematol. 2010;85:174–180. - PubMed
-
- Provan D., Stasi R., Newland A.C., Blanchette V.S., Bolton-maggs P., Bussel J.B., Chong H., Cines D.B., Gernsheimer T.B., Godeau B., et al. Review article International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–186. doi: 10.1182/blood-2009-06-225565. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous